English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

Cardiomyopathies are mostly determined by genetic mutations affecting either cardiac muscle cell structure or function. Nevertheless, cardiomyopathies may also be part of complex clinical phenotypes in the spectrum of neuromuscular (NMD) or mitochondrial diseases (MD). The aim of this study is to describe the clinical, molecular, and histological characteristics of a consecutive cohort of patients with cardiomyopathy associated with NMDs or MDs referred to a tertiary cardiomyopathy clinic. Consecutive patients with a definitive diagnosis of NMDs and MDs presenting with a cardiomyopathy phenotype were described. Seven patients were identified: two patients with ACAD9 deficiency ( Patient 1 carried the c.1240C&gt;T (p.Arg414Cys) homozygous variant in ACAD9 ; Patient 2 carried the c.1240C&gt;T (p.Arg414Cys) and the c.1646G&gt;A (p.Ar549Gln) variants in ACAD9 ); two patients with MYH7 -related myopathy ( Patient 3 carried the c.1325G&gt;A (p.Arg442His) variant in MYH7 ; Patient 4 carried the c.1357C&gt;T (p.Arg453Cys) variant in MYH7 ); one patient with desminopathy ( Patient 5 carried the c.46C&gt;T (p.Arg16Cys) variant in DES ); two patients with mitochondrial myopathy ( Patient 6 carried the m.3243A&gt;G variant in MT-TL1 ; Patient 7 carried the c.253G&gt;A (p.Gly85Arg) and the c.1055C&gt;T (p.Thr352Met) variants in MTO1 ). All patients underwent a comprehensive cardiovascular and neuromuscular evaluation, including muscle biopsy and genetic testing. This study described the clinical phenotype of rare NMDs and MDs presenting as cardiomyopathies. A multidisciplinary evaluation, combined with genetic testing, plays a main role in the diagnosis of these rare diseases, and provides information about clinical expectations, and guides management.

international journal of molecular sciences

Clinical, Genetic, and Histological Characterization of Patients with Rare Neuromuscular and Mitochondrial Diseases Presenting with Different Cardiomyopathy Phenotypes